Plain-English translation of NCT06475170 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new surgical approach called 'λ+α double-tract reconstruction' for patients with early-stage stomach cancer located in the upper third of the stomach. After removing the cancerous part of the stomach, surgeons use this new reconstruction method to reconnect the remaining digestive tract. The goal is to preserve as much of your stomach as possible while preventing acid reflux — a common problem after this type of surgery.
Stomach cancer in the upper region is becoming more common, and doctors want to find the best surgical technique that removes cancer effectively while maintaining quality of life and preventing reflux problems. The ideal reconstruction method hasn't been firmly established yet, so this trial compares the new technique to standard approaches.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo laparoscopic (minimally invasive) surgery to remove the upper portion of your stomach, and surgeons will use the new 'λ+α double-tract reconstruction' technique to reconnect your digestive tract. The trial will monitor your recovery and quality of life, including tracking how well the surgery prevents reflux and how you're doing overall. You'll be compared against patients who receive the standard surgical reconstruction method to see if the new approach works better.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China